99 related articles for article (PubMed ID: 9636294)
1. A high capacity assay for inhibitors of human papillomavirus DNA replication.
Plumpton M; Sharp NA; Liddicoat LH; Remm M; Tucker DO; Hughes FJ; Russell SM; Romanos MA
Biotechnology (N Y); 1995 Nov; 13(11):1210-4. PubMed ID: 9636294
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression.
Hubert WG; Laimins LA
J Virol; 2002 Mar; 76(5):2263-73. PubMed ID: 11836404
[TBL] [Abstract][Full Text] [Related]
3. The E8E2C protein, a negative regulator of viral transcription and replication, is required for extrachromosomal maintenance of human papillomavirus type 31 in keratinocytes.
Stubenrauch F; Hummel M; Iftner T; Laimins LA
J Virol; 2000 Feb; 74(3):1178-86. PubMed ID: 10627528
[TBL] [Abstract][Full Text] [Related]
4. Transient replication of human papillomavirus DNAs.
Del Vecchio AM; Romanczuk H; Howley PM; Baker CC
J Virol; 1992 Oct; 66(10):5949-58. PubMed ID: 1326651
[TBL] [Abstract][Full Text] [Related]
5. A novel drug screening assay for papillomavirus specific antiviral activity.
Clark PR; Roberts ML; Cowsert LM
Antiviral Res; 1998 Feb; 37(2):97-106. PubMed ID: 9588842
[TBL] [Abstract][Full Text] [Related]
6. Development of quantitative and high-throughput assays of polyomavirus and papillomavirus DNA replication.
Fradet-Turcotte A; Morin G; Lehoux M; Bullock PA; Archambault J
Virology; 2010 Mar; 399(1):65-76. PubMed ID: 20079917
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human papillomavirus DNA replication by small molecule antagonists of the E1-E2 protein interaction.
White PW; Titolo S; Brault K; Thauvette L; Pelletier A; Welchner E; Bourgon L; Doyon L; Ogilvie WW; Yoakim C; Cordingley MG; Archambault J
J Biol Chem; 2003 Jul; 278(29):26765-72. PubMed ID: 12730224
[TBL] [Abstract][Full Text] [Related]
8. E1 protein of human papillomavirus type 1a is sufficient for initiation of viral DNA replication.
Gopalakrishnan V; Khan SA
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9597-601. PubMed ID: 7937813
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus-16 and -18 replication in esophagus squamous cancer cell lines does not require heterologous E1 and E2 proteins.
Togawa K; Rustgi AK
J Med Virol; 1995 Apr; 45(4):435-8. PubMed ID: 7666044
[TBL] [Abstract][Full Text] [Related]
10. DNA replication specificity and functional E2 interaction of the E1 proteins of human papillomavirus types 1a and 18 are determined by their carboxyl-terminal halves.
Gopalakrishnan V; Sheahan L; Khan SA
Virology; 1999 Apr; 256(2):330-9. PubMed ID: 10191198
[TBL] [Abstract][Full Text] [Related]
11. Regulation of human papillomavirus type 16 DNA replication by E2, glucocorticoid hormone and epidermal growth factor.
Piccini A; Storey A; Romanos M; Banks L
J Gen Virol; 1997 Aug; 78 ( Pt 8)():1963-70. PubMed ID: 9266995
[TBL] [Abstract][Full Text] [Related]
12. Association of the human papillomavirus type 11 E1 protein with histone H1.
Swindle CS; Engler JA
J Virol; 1998 Mar; 72(3):1994-2001. PubMed ID: 9499053
[TBL] [Abstract][Full Text] [Related]
13. Identification of peptides that inhibit the DNA binding, trans-activator, and DNA replication functions of the human papillomavirus type 11 E2 protein.
Deng SJ; Pearce KH; Dixon EP; Hartley KA; Stanley TB; Lobe DC; Garvey EP; Kost TA; Petty RL; Rocque WJ; Alexander KA; Underwood MR
J Virol; 2004 Mar; 78(5):2637-41. PubMed ID: 14963172
[TBL] [Abstract][Full Text] [Related]
14. Development of human papillomavirus plasmids capable of episomal replication in human cell lines.
Sverdrup F; Sheahan L; Khan S
Gene Ther; 1999 Jul; 6(7):1317-21. PubMed ID: 10455442
[TBL] [Abstract][Full Text] [Related]
15. Human TATA binding protein inhibits human papillomavirus type 11 DNA replication by antagonizing E1-E2 protein complex formation on the viral origin of replication.
Hartley KA; Alexander KA
J Virol; 2002 May; 76(10):5014-23. PubMed ID: 11967317
[TBL] [Abstract][Full Text] [Related]
16. A quantitative and high-throughput assay of human papillomavirus DNA replication.
Gagnon D; Fradet-Turcotte A; Archambault J
Methods Mol Biol; 2015; 1249():305-16. PubMed ID: 25348316
[TBL] [Abstract][Full Text] [Related]
17. Two E2 binding sites alone are sufficient to function as the minimal origin of replication of human papillomavirus type 18 DNA.
Sverdrup F; Khan SA
J Virol; 1995 Feb; 69(2):1319-23. PubMed ID: 7815514
[TBL] [Abstract][Full Text] [Related]
18. The E1 helicase of human papillomavirus type 11 binds to the origin of replication with low sequence specificity.
Dixon EP; Pahel GL; Rocque WJ; Barnes JA; Lobe DC; Hanlon MH; Alexander KA; Chao SF; Lindley K; Phelps WC
Virology; 2000 May; 270(2):345-57. PubMed ID: 10792994
[TBL] [Abstract][Full Text] [Related]
19. DNA replicative functions of highly-expressed, codon-optimized human papillomavirus proteins E1 and E2.
Wang XM; Jansen KU; McClements WL
J Virol Methods; 2003 Mar; 108(1):83-90. PubMed ID: 12565157
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus E1 and E2 mediated DNA replication is not arrested by DNA damage signalling.
King LE; Fisk JC; Dornan ES; Donaldson MM; Melendy T; Morgan IM
Virology; 2010 Oct; 406(1):95-102. PubMed ID: 20673941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
